Diagnosis and management of pergolide‐induced fibrosis
Identifieur interne : 003D47 ( Main/Exploration ); précédent : 003D46; suivant : 003D48Diagnosis and management of pergolide‐induced fibrosis
Auteurs : Pinky Agarwal [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-06.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Biopsy, Needle, Bronchi (pathology), Clinical management, Diagnosis, Female, Fibrosis, Fibrosis (chemically induced), Fibrosis (diagnosis), Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nervous system diseases, Parkinson Disease (diagnosis), Parkinson Disease (drug therapy), Pergolide, Pergolide (adverse effects), Pergolide (therapeutic use), Pleural Diseases (chemically induced), Pleural Diseases (diagnosis), Retroperitoneal Fibrosis (chemically induced), Retroperitoneal Fibrosis (diagnosis), Tomography, X-Ray Computed, pergolide, pleural fibrosis, retroperitoneal fibrosis, surgery.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Pergolide.
- chemical , therapeutic use : Antiparkinson Agents, Pergolide.
- chemically induced : Fibrosis, Pleural Diseases, Retroperitoneal Fibrosis.
- diagnosis : Fibrosis, Parkinson Disease, Pleural Diseases, Retroperitoneal Fibrosis.
- drug therapy : Parkinson Disease.
- pathology : Bronchi.
- Aged, Aged, 80 and over, Biopsy, Needle, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Tomography, X-Ray Computed.
Abstract
We report on 2 patients treated with pergolide, 1 of whom developed pleural fibrosis and the other retroperitoneal fibrosis. In both cases, an extensive diagnostic evaluation and surgical intervention were required to reach a diagnosis. Based on our experience with these patients and a review of cases of pergolide‐induced fibrosis in the English‐language literature, we propose guidelines for the diagnosis and management of this rare complication. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20200
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003235
- to stream Istex, to step Curation: 003235
- to stream Istex, to step Checkpoint: 002728
- to stream PubMed, to step Corpus: 003435
- to stream PubMed, to step Curation: 003435
- to stream PubMed, to step Checkpoint: 003494
- to stream Ncbi, to step Merge: 000E49
- to stream Ncbi, to step Curation: 000E49
- to stream Ncbi, to step Checkpoint: 000E49
- to stream Main, to step Merge: 005705
- to stream PascalFrancis, to step Corpus: 002148
- to stream PascalFrancis, to step Curation: 000B73
- to stream PascalFrancis, to step Checkpoint: 002181
- to stream Main, to step Merge: 005A19
- to stream Main, to step Curation: 003D47
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diagnosis and management of pergolide‐induced fibrosis</title><author><name sortKey="Agarwal, Pinky" sort="Agarwal, Pinky" uniqKey="Agarwal P" first="Pinky" last="Agarwal">Pinky Agarwal</name></author><author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name></author><author><name sortKey="Frucht, Steven J" sort="Frucht, Steven J" uniqKey="Frucht S" first="Steven J." last="Frucht">Steven J. Frucht</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:60CCC67FD59FA5193D80384BBCDA21B8513BAD72</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1002/mds.20200</idno><idno type="url">https://api.istex.fr/document/60CCC67FD59FA5193D80384BBCDA21B8513BAD72/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003235</idno><idno type="wicri:Area/Istex/Curation">003235</idno><idno type="wicri:Area/Istex/Checkpoint">002728</idno><idno type="wicri:doubleKey">0885-3185:2004:Agarwal P:diagnosis:and:management</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15197712</idno><idno type="wicri:Area/PubMed/Corpus">003435</idno><idno type="wicri:Area/PubMed/Curation">003435</idno><idno type="wicri:Area/PubMed/Checkpoint">003494</idno><idno type="wicri:Area/Ncbi/Merge">000E49</idno><idno type="wicri:Area/Ncbi/Curation">000E49</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E49</idno><idno type="wicri:doubleKey">0885-3185:2004:Agarwal P:diagnosis:and:management</idno><idno type="wicri:Area/Main/Merge">005705</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0415276</idno><idno type="wicri:Area/PascalFrancis/Corpus">002148</idno><idno type="wicri:Area/PascalFrancis/Curation">000B73</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002181</idno><idno type="wicri:doubleKey">0885-3185:2004:Agarwal P:diagnosis:and:management</idno><idno type="wicri:Area/Main/Merge">005A19</idno><idno type="wicri:Area/Main/Curation">003D47</idno><idno type="wicri:Area/Main/Exploration">003D47</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Diagnosis and management of pergolide‐induced fibrosis</title><author><name sortKey="Agarwal, Pinky" sort="Agarwal, Pinky" uniqKey="Agarwal P" first="Pinky" last="Agarwal">Pinky Agarwal</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Columbia‐Presbyterian Medical Center, Division of Movement Disorders, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Columbia‐Presbyterian Medical Center, Division of Movement Disorders, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Frucht, Steven J" sort="Frucht, Steven J" uniqKey="Frucht S" first="Steven J." last="Frucht">Steven J. Frucht</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Columbia‐Presbyterian Medical Center, Division of Movement Disorders, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2004-06">2004-06</date><biblScope unit="vol">19</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="699">699</biblScope><biblScope unit="page" to="704">704</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">60CCC67FD59FA5193D80384BBCDA21B8513BAD72</idno><idno type="DOI">10.1002/mds.20200</idno><idno type="ArticleID">MDS20200</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Biopsy, Needle</term><term>Bronchi (pathology)</term><term>Clinical management</term><term>Diagnosis</term><term>Female</term><term>Fibrosis</term><term>Fibrosis (chemically induced)</term><term>Fibrosis (diagnosis)</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (drug therapy)</term><term>Pergolide</term><term>Pergolide (adverse effects)</term><term>Pergolide (therapeutic use)</term><term>Pleural Diseases (chemically induced)</term><term>Pleural Diseases (diagnosis)</term><term>Retroperitoneal Fibrosis (chemically induced)</term><term>Retroperitoneal Fibrosis (diagnosis)</term><term>Tomography, X-Ray Computed</term><term>pergolide</term><term>pleural fibrosis</term><term>retroperitoneal fibrosis</term><term>surgery</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Pergolide</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Pergolide</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Fibrosis</term><term>Pleural Diseases</term><term>Retroperitoneal Fibrosis</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Fibrosis</term><term>Parkinson Disease</term><term>Pleural Diseases</term><term>Retroperitoneal Fibrosis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Bronchi</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Biopsy, Needle</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Male</term><term>Middle Aged</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Conduite à tenir</term><term>Diagnostic</term><term>Fibrose</term><term>Pergolide</term><term>Système nerveux pathologie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on 2 patients treated with pergolide, 1 of whom developed pleural fibrosis and the other retroperitoneal fibrosis. In both cases, an extensive diagnostic evaluation and surgical intervention were required to reach a diagnosis. Based on our experience with these patients and a review of cases of pergolide‐induced fibrosis in the English‐language literature, we propose guidelines for the diagnosis and management of this rare complication. © 2004 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Agarwal, Pinky" sort="Agarwal, Pinky" uniqKey="Agarwal P" first="Pinky" last="Agarwal">Pinky Agarwal</name></region><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name><name sortKey="Frucht, Steven J" sort="Frucht, Steven J" uniqKey="Frucht S" first="Steven J." last="Frucht">Steven J. Frucht</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:60CCC67FD59FA5193D80384BBCDA21B8513BAD72
|texte= Diagnosis and management of pergolide‐induced fibrosis
}}
| This area was generated with Dilib version V0.6.23. |  |